Literature DB >> 9739012

Characterization of recurrent homogeneously staining regions in 72 breast carcinomas.

J Bernardino1, F Apiou, M Gerbault-Seureau, B Malfoy, B Dutrillaux.   

Abstract

Cytogenetic analyses were performed on 223 breast carcinomas, of which 60% contained homogeneously staining regions (hsr), an intrachromosomal cytogenetic feature of gene amplification. The precise hsr localization could be determined for 123 hsr from 72 cases. The juxtacentromeric region of chromosome 8, band 11q13, and the whole of chromosome 17 were frequently involved. For 28 cases, the origin of the DNA sequences forming HSR could be investigated by chromosome painting, comparative genomic hybridization, and/or Southern blotting. Sequences from chromosomes 11 and 17 were mostly found within hsr located on chromosomes 11 and 17, respectively. In contrast, sequences from chromosome 8 were rarely found within hsr localized on chromosome 8. These observations suggest that different mechanisms lead to hsr formation in breast cancer. Band 11 q13 and the 17p chromosome arm may correspond to sites of in situ amplification driven by deletions distal to the amplification target genes. hsr in the region 17q2, which is also a frequent site of in situ amplification, takes place without the occurrence of a distal deletion. The short arm of chromosome 8 is often deleted, but frequently becomes the site of hsr formed elsewhere in the genome.

Entities:  

Mesh:

Year:  1998        PMID: 9739012     DOI: 10.1002/(sici)1098-2264(199810)23:2<100::aid-gcc2>3.0.co;2-6

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  4 in total

1.  Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.

Authors:  Alison M Schram; Igor Odintsov; Madelyn Espinosa-Cotton; Inna Khodos; Whitney J Sisso; Marissa S Mattar; Allan J W Lui; Morana Vojnic; Sara H Shameem; Thrusha Chauhan; Jean Torrisi; Jim Ford; Marie N O'Connor; Cecile A W Geuijen; Ron C J Schackmann; Jeroen J Lammerts van Bueren; Ernesto Wasserman; Elisa de Stanchina; Eileen M O'Reilly; Marc Ladanyi; Alexander Drilon; Romel Somwar
Journal:  Cancer Discov       Date:  2022-05-02       Impact factor: 38.272

2.  Molecular cytogenetic analysis of breast cancer cell lines.

Authors:  J M Davidson; K L Gorringe; S F Chin; B Orsetti; C Besret; C Courtay-Cahen; I Roberts; C Theillet; C Caldas; P A Edwards
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

3.  Amplicon rearrangements during the extrachromosomal and intrachromosomal amplification process in a glioma.

Authors:  Nicolas Vogt; Anne Gibaud; Frédéric Lemoine; Pierre de la Grange; Michelle Debatisse; Bernard Malfoy
Journal:  Nucleic Acids Res       Date:  2014-11-06       Impact factor: 16.971

4.  Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer.

Authors:  Manal F Ismail; Magdy Sayed Aly; Hussein M Khaled; Hanaa M Mohamed
Journal:  Ger Med Sci       Date:  2009-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.